Gavi Begins Major Typhoid Vaccination Campaign Against Outbreak In Zimbabwe 22/02/2019 by William New Geneva-based Gavi, the Vaccine Alliance, today announced the start of a major two-week campaign to vaccinate hundreds of thousands of people in Harare, Zimbabwe against typhoid, after an outbreak there. The campaign will be the first in Africa to use a new typhoid vaccine that can be administered to young children and is long-lasting. Nearly 2,000 cases of typhoid have been reported since a second wave of outbreak arose in September, Gavi said. Continue reading -> Suzette Kox Named Secretary General Of International Generic And Biosimilar Medicines Association 22/02/2019 by William New The Geneva-based International Generic and Biosimilar medicines Association (IGBA) has named industry veteran Suzette Kox as secretary general. Image Credits: International Generic and Biosimilar medicines Association. Continue reading -> WHO: Global Health Expenditure Rising But Public Outlays Lag In Low Income Countries 20/02/2019 by Elaine Ruth Fletcher Global health expenditure is rising worldwide, and the pace is most rapid in low- and middle-income countries where growth in all forms of spending (public, private and donor aid) is now averaging 6% annually as compared to 4% in high-income countries, according to a World Health Organization report released today. Continue reading -> Report Details Health Crisis Hidden In Plastics Lifecycle 19/02/2019 by William New A new report released today and authored by a range of environment and health groups pulls together research that "exposes distinct toxic risks plastic poses to human health at every stage of the plastic lifecycle, from extraction of fossil fuels, to consumer use, to disposal and beyond." Continue reading -> New Joint Initiative For More Efficient, Adaptable Clinical Practice Guidelines 19/02/2019 by David Branigan Wellcome Trust, the Bill & Melinda Gates Foundation and the African Academy of Sciences have joined together in a new initiative to make clinical practice guidelines more efficient and adaptable for clinical trials that require less stringent approaches, such as those that take place during infectious disease outbreaks. Additionally, by applying a more flexible approach towards the application of these guidelines, the initiative also hopes to make them “future proof,” or able to better incorporate new technologies. Continue reading -> Italy Floats Proposal For New Deal On Drug Pricing At World Health Assembly 18/02/2019 by Elaine Ruth Fletcher Italian Health Minister Giulia Grillo has proposed that sweeping reforms be considered by the World Health Organization and its member states to increase global transparency of drug prices -- which may be unaffordable to most people in the developing world and increasingly costly for patients and health systems in high-income countries. Continue reading -> WHO Rocks To The “Sound Of Life” At Launch Of WHO-ITU Safe Listening Standard 15/02/2019 by David Branigan Grammy award-winning musician Ricky Kej performed a “Sound of Life” concert at the World Health Organization to help launch the first-ever global standard for safe listening devices, aimed at raising awareness and inspiring action to prevent sound-induced hearing loss. Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 by Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 by David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 by David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> Posts navigation Older posts
Suzette Kox Named Secretary General Of International Generic And Biosimilar Medicines Association 22/02/2019 by William New The Geneva-based International Generic and Biosimilar medicines Association (IGBA) has named industry veteran Suzette Kox as secretary general. Image Credits: International Generic and Biosimilar medicines Association. Continue reading -> WHO: Global Health Expenditure Rising But Public Outlays Lag In Low Income Countries 20/02/2019 by Elaine Ruth Fletcher Global health expenditure is rising worldwide, and the pace is most rapid in low- and middle-income countries where growth in all forms of spending (public, private and donor aid) is now averaging 6% annually as compared to 4% in high-income countries, according to a World Health Organization report released today. Continue reading -> Report Details Health Crisis Hidden In Plastics Lifecycle 19/02/2019 by William New A new report released today and authored by a range of environment and health groups pulls together research that "exposes distinct toxic risks plastic poses to human health at every stage of the plastic lifecycle, from extraction of fossil fuels, to consumer use, to disposal and beyond." Continue reading -> New Joint Initiative For More Efficient, Adaptable Clinical Practice Guidelines 19/02/2019 by David Branigan Wellcome Trust, the Bill & Melinda Gates Foundation and the African Academy of Sciences have joined together in a new initiative to make clinical practice guidelines more efficient and adaptable for clinical trials that require less stringent approaches, such as those that take place during infectious disease outbreaks. Additionally, by applying a more flexible approach towards the application of these guidelines, the initiative also hopes to make them “future proof,” or able to better incorporate new technologies. Continue reading -> Italy Floats Proposal For New Deal On Drug Pricing At World Health Assembly 18/02/2019 by Elaine Ruth Fletcher Italian Health Minister Giulia Grillo has proposed that sweeping reforms be considered by the World Health Organization and its member states to increase global transparency of drug prices -- which may be unaffordable to most people in the developing world and increasingly costly for patients and health systems in high-income countries. Continue reading -> WHO Rocks To The “Sound Of Life” At Launch Of WHO-ITU Safe Listening Standard 15/02/2019 by David Branigan Grammy award-winning musician Ricky Kej performed a “Sound of Life” concert at the World Health Organization to help launch the first-ever global standard for safe listening devices, aimed at raising awareness and inspiring action to prevent sound-induced hearing loss. Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 by Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 by David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 by David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> Posts navigation Older posts
WHO: Global Health Expenditure Rising But Public Outlays Lag In Low Income Countries 20/02/2019 by Elaine Ruth Fletcher Global health expenditure is rising worldwide, and the pace is most rapid in low- and middle-income countries where growth in all forms of spending (public, private and donor aid) is now averaging 6% annually as compared to 4% in high-income countries, according to a World Health Organization report released today. Continue reading -> Report Details Health Crisis Hidden In Plastics Lifecycle 19/02/2019 by William New A new report released today and authored by a range of environment and health groups pulls together research that "exposes distinct toxic risks plastic poses to human health at every stage of the plastic lifecycle, from extraction of fossil fuels, to consumer use, to disposal and beyond." Continue reading -> New Joint Initiative For More Efficient, Adaptable Clinical Practice Guidelines 19/02/2019 by David Branigan Wellcome Trust, the Bill & Melinda Gates Foundation and the African Academy of Sciences have joined together in a new initiative to make clinical practice guidelines more efficient and adaptable for clinical trials that require less stringent approaches, such as those that take place during infectious disease outbreaks. Additionally, by applying a more flexible approach towards the application of these guidelines, the initiative also hopes to make them “future proof,” or able to better incorporate new technologies. Continue reading -> Italy Floats Proposal For New Deal On Drug Pricing At World Health Assembly 18/02/2019 by Elaine Ruth Fletcher Italian Health Minister Giulia Grillo has proposed that sweeping reforms be considered by the World Health Organization and its member states to increase global transparency of drug prices -- which may be unaffordable to most people in the developing world and increasingly costly for patients and health systems in high-income countries. Continue reading -> WHO Rocks To The “Sound Of Life” At Launch Of WHO-ITU Safe Listening Standard 15/02/2019 by David Branigan Grammy award-winning musician Ricky Kej performed a “Sound of Life” concert at the World Health Organization to help launch the first-ever global standard for safe listening devices, aimed at raising awareness and inspiring action to prevent sound-induced hearing loss. Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 by Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 by David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 by David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> Posts navigation Older posts
Report Details Health Crisis Hidden In Plastics Lifecycle 19/02/2019 by William New A new report released today and authored by a range of environment and health groups pulls together research that "exposes distinct toxic risks plastic poses to human health at every stage of the plastic lifecycle, from extraction of fossil fuels, to consumer use, to disposal and beyond." Continue reading -> New Joint Initiative For More Efficient, Adaptable Clinical Practice Guidelines 19/02/2019 by David Branigan Wellcome Trust, the Bill & Melinda Gates Foundation and the African Academy of Sciences have joined together in a new initiative to make clinical practice guidelines more efficient and adaptable for clinical trials that require less stringent approaches, such as those that take place during infectious disease outbreaks. Additionally, by applying a more flexible approach towards the application of these guidelines, the initiative also hopes to make them “future proof,” or able to better incorporate new technologies. Continue reading -> Italy Floats Proposal For New Deal On Drug Pricing At World Health Assembly 18/02/2019 by Elaine Ruth Fletcher Italian Health Minister Giulia Grillo has proposed that sweeping reforms be considered by the World Health Organization and its member states to increase global transparency of drug prices -- which may be unaffordable to most people in the developing world and increasingly costly for patients and health systems in high-income countries. Continue reading -> WHO Rocks To The “Sound Of Life” At Launch Of WHO-ITU Safe Listening Standard 15/02/2019 by David Branigan Grammy award-winning musician Ricky Kej performed a “Sound of Life” concert at the World Health Organization to help launch the first-ever global standard for safe listening devices, aimed at raising awareness and inspiring action to prevent sound-induced hearing loss. Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 by Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 by David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 by David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> Posts navigation Older posts
New Joint Initiative For More Efficient, Adaptable Clinical Practice Guidelines 19/02/2019 by David Branigan Wellcome Trust, the Bill & Melinda Gates Foundation and the African Academy of Sciences have joined together in a new initiative to make clinical practice guidelines more efficient and adaptable for clinical trials that require less stringent approaches, such as those that take place during infectious disease outbreaks. Additionally, by applying a more flexible approach towards the application of these guidelines, the initiative also hopes to make them “future proof,” or able to better incorporate new technologies. Continue reading -> Italy Floats Proposal For New Deal On Drug Pricing At World Health Assembly 18/02/2019 by Elaine Ruth Fletcher Italian Health Minister Giulia Grillo has proposed that sweeping reforms be considered by the World Health Organization and its member states to increase global transparency of drug prices -- which may be unaffordable to most people in the developing world and increasingly costly for patients and health systems in high-income countries. Continue reading -> WHO Rocks To The “Sound Of Life” At Launch Of WHO-ITU Safe Listening Standard 15/02/2019 by David Branigan Grammy award-winning musician Ricky Kej performed a “Sound of Life” concert at the World Health Organization to help launch the first-ever global standard for safe listening devices, aimed at raising awareness and inspiring action to prevent sound-induced hearing loss. Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 by Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 by David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 by David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> Posts navigation Older posts
Italy Floats Proposal For New Deal On Drug Pricing At World Health Assembly 18/02/2019 by Elaine Ruth Fletcher Italian Health Minister Giulia Grillo has proposed that sweeping reforms be considered by the World Health Organization and its member states to increase global transparency of drug prices -- which may be unaffordable to most people in the developing world and increasingly costly for patients and health systems in high-income countries. Continue reading -> WHO Rocks To The “Sound Of Life” At Launch Of WHO-ITU Safe Listening Standard 15/02/2019 by David Branigan Grammy award-winning musician Ricky Kej performed a “Sound of Life” concert at the World Health Organization to help launch the first-ever global standard for safe listening devices, aimed at raising awareness and inspiring action to prevent sound-induced hearing loss. Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 by Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 by David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 by David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> Posts navigation Older posts
WHO Rocks To The “Sound Of Life” At Launch Of WHO-ITU Safe Listening Standard 15/02/2019 by David Branigan Grammy award-winning musician Ricky Kej performed a “Sound of Life” concert at the World Health Organization to help launch the first-ever global standard for safe listening devices, aimed at raising awareness and inspiring action to prevent sound-induced hearing loss. Continue reading -> ‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 by Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 by David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 by David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> Posts navigation Older posts
‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs 14/02/2019 by Elaine Ruth Fletcher An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading -> WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 by David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 by David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> Posts navigation Older posts
WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 by David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 by David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> Posts navigation Older posts
New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 by David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> Posts navigation Older posts